Dr. CVS is Coming, But the Company Will Face Crowded Competition to Build It
By James O’Donnell For JP Weiss, a pharmacy technician at a CVS store in California, he’s seen first hand that business has been booming for the healthcare giant.
A take on business from Times Square
Sponsored by NYC News Service and CUNY Newmark J-School
Reporter
By James O’Donnell For JP Weiss, a pharmacy technician at a CVS store in California, he’s seen first hand that business has been booming for the healthcare giant.
To JP Weiss, a pharmacy technician at a CVS store in California, business has been booming for the healthcare giant.
Even amid economic uncertainty, American Express will invest further in the credit card model that’s paid off this year: spending heavily on marketing to target wealthy clientele with membership perks, all while raking in high fees.
Ahead of CVS’s third quarter earnings release on Wednesday, experts predict the health giant’s positive trends will continue in the short run: sizable profits and revenues thanks to lucrative pharmacy benefit management contracts and strong demand for health care services since the pandemic.
In what would be a deeper plunge into the primary care space, CVS is considering an acquisition of Cano Health.
Investors dismayed by the market’s dramatic decline and global rate hike uncertainty may find a remedy in resilient health insurer stocks.
About the Journal
The Times Square Investment Journal covers companies, markets and personal finance from a newsroom in the heart of Manhattan. The Journal is sponsored by the NYC News Service and the Craig Newmark Graduate School of Journalism at CUNY.
Send comments and story tips to the editor.
greg.david@journalism.cuny.edu